Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
eNq1mFFv2jAQx9/5FFHeSYDSkk6BamPthtSqjBZt2ktlkqOYuXZ6doDu088hVEsnZy2mfoM4+d/F9/fvTonPNg/MWwFKKnjfbwct3wOeiJTy+74/vb1oRv7ZoBEvyYpUbusFraDd8b2EESn7frEazIBwGfy4uvwM+nlAf9DwYjFbQqJe3JcryoKvRC6uSFbc48UrQVPvAdRCpH0/y9X2qhdLhTqLwVrgL5mRBOJwd6W6urzrVq/HYSH2BtVcAl4Sfm8UnaOVZpIjAldDouBe4JNZOrnrRL2TViuyCkHlBKTIMYExUYsxihVNITVHIkyCVZD5Or0BXDFQRRCjeLhMHqSVOFmSzQQeR+akP+rVodqoZqvZ7nVP2setTjs6bfesQmFlq8zm0S8RZhmmd53T6Pgo6oVzDFMUDDJFeFP/ygBpKphlrcYCFWGOqkTl8KXfHMVBeHzVDSmVGSNPwVJmtltFkOhlQE0Fdy9SvMEtak4xvWf/6POcsXDPrKc7ijjKuIDUUORc1cDkYmK7EUPBFWzqK2rHP7XZeZGCfD/Z34Kb2T/OZ4wmtojTEMpBqulkVE84l3D4RCRM0R0dvlOeirV8f+pUq+wo+2wLzv800G4URdZH6qc2VE3/Oc+LsoaaRlQeApkRn4tD8aI9apZ6dqgzc26HI5EQBjXjUdOSPNqVz9OcM9+7O1PlglH0y/mtrV2+5YBPN9u/Rmma9quFtiOzC9xrf9bmvr/byyP/htm5Gx117FyNZqIslMrkhzBcr9fBgsimJHqzAn2eXHeAShN2N8k76fTl5FNy1FHqs7I97lcx2zP42ixw6Hy7e343RxtjKMzhgFqUuHYG1dH5+3P673DrLO3xC6i4C7MdRImigrsaiPKZUfHgzqBLyy9QM+J6Pqc131hqrRmH5fedQSMOi287g8Yf5AEEoQ==
3RjRfvp597KbzLmc